Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
NCT ID: NCT04447534
Last Updated: 2022-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
191 participants
INTERVENTIONAL
2020-06-23
2020-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19
NCT04361318
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
NCT04261517
Hydroxychloroquine for Treatment of Non-Severe COVID-19
NCT04860284
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
NCT04377646
Hydroxychloroquine in COVID-19 Patients
NCT04394442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chloroquine or hydroxychloroquine
Chloroquine or hydroxychloroquine alone
Chloroquine or hydroxychloroquine
Chloroquine or hydroxychloroquine
Chloroquine or hydroxychloroquine with zinc
Chloroquine or hydroxychloroquine with zinc
Chloroquine or hydroxychloroquine
Chloroquine or hydroxychloroquine
zinc
Zinc tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chloroquine or hydroxychloroquine
Chloroquine or hydroxychloroquine
zinc
Zinc tablets
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sherief Abd-Elsalam, Ass. Prof.
Role: PRINCIPAL_INVESTIGATOR
ass. Prof. Tropical Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university hospital, Assuit University, Ainshams University
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abd-Elsalam S, Soliman S, Esmail ES, Khalaf M, Mostafa EF, Medhat MA, Ahmed OA, El Ghafar MSA, Alboraie M, Hassany SM. Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial. Biol Trace Elem Res. 2021 Oct;199(10):3642-3646. doi: 10.1007/s12011-020-02512-1. Epub 2020 Nov 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tanta zinc chloroquine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.